CDK12 also plays a role in some ovarian cancers. Subscribe to Technology Networks ... engineered mouse model that parallels ...

Pheast Therapeutics ("Pheast"), a biotech developing novel macrophage checkpoint therapies to defy cancer, today announced the presentation of new preclinical data for PHST001, an anti-CD24 antibody ...

It’s being examined in a phase 1/2a study designed to enroll up to 15 patients for each of six different cohorts, spanning ...

People inherit two copies of each gene—one from each parent—an evolutionary fail-safe to ensure survival even when one of ...

Onchilles Pharma Presents New Preclinical Data for the Systemically Delivered NEU-002 Program Targeting the ELANE Pathway at ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each ...

Corcept's upcoming Q4 announcements include pivotal trial results for Relacorilant in ovarian cancer ... While Corcept's mouse model data above look quite favorable, there is always risk in ...

When Gilkes’ team exposed cells to hypoxia for a longer period — five days was usually enough — they mimicked what was ...

Scientists have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop ...

Findings indicate ovarian cancer disrupts CD8+ T cell metabolism through FABP5 and TAGLN2, suggesting new therapeutic targets ...

Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...